Caseware UK (AP4) 2025.0.111 2025.0.111 2026-01-312026-01-312025-02-01falseSpecialists medical practice activities22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14617694 2025-02-01 2026-01-31 14617694 2024-02-01 2025-01-31 14617694 2026-01-31 14617694 2025-01-31 14617694 c:Director1 2025-02-01 2026-01-31 14617694 d:PlantMachinery 2025-02-01 2026-01-31 14617694 d:PlantMachinery 2026-01-31 14617694 d:PlantMachinery 2025-01-31 14617694 d:PlantMachinery d:OwnedOrFreeholdAssets 2025-02-01 2026-01-31 14617694 d:CurrentFinancialInstruments 2026-01-31 14617694 d:CurrentFinancialInstruments 2025-01-31 14617694 d:CurrentFinancialInstruments d:WithinOneYear 2026-01-31 14617694 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 14617694 d:ShareCapital 2026-01-31 14617694 d:ShareCapital 2025-01-31 14617694 d:RetainedEarningsAccumulatedLosses 2026-01-31 14617694 d:RetainedEarningsAccumulatedLosses 2025-01-31 14617694 c:FRS102 2025-02-01 2026-01-31 14617694 c:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 14617694 c:FullAccounts 2025-02-01 2026-01-31 14617694 c:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 14617694 e:PoundSterling 2025-02-01 2026-01-31 iso4217:GBP xbrli:pure

Registered number: 14617694









EARLY BREAST AWARE LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JANUARY 2026

 
EARLY BREAST AWARE LTD
REGISTERED NUMBER: 14617694

BALANCE SHEET
AS AT 31 JANUARY 2026

2026
2025
Note
£
£

Fixed assets
  

Tangible assets
 4 
8,402
9,573

  
8,402
9,573

Current assets
  

Debtors: amounts falling due within one year
 5 
6,050
8,200

Cash at bank and in hand
 6 
29,814
24,136

  
35,864
32,336

Creditors: amounts falling due within one year
 7 
(11,004)
(18,467)

Net current assets
  
 
 
24,860
 
 
13,869

Total assets less current liabilities
  
33,262
23,442

  

Net assets
  
33,262
23,442


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
33,162
23,342

  
33,262
23,442


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 October 2026.



Page 1

 
EARLY BREAST AWARE LTD
REGISTERED NUMBER: 14617694
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2026


Dawn McDonald Chaplin
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
EARLY BREAST AWARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1.


General information

Early Breast Aware Ltd is a company limited by shares incorporated in England within the United Kingdom, having a registration number of 14617694. The address of the registered office is 77 Francis Road, Edgbaston, Birmingham, England, B16 8SP. The principal activity of the company in the year under review was that of specialists medical practice activities.

The financial statements are presented in sterling which is functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006 and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liabilities Partnerships'. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements has been prepared on a going concern basis which assumes that the company will continue to receive support from creditors and the director as and when required.

Page 3

 
EARLY BREAST AWARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
∙the Company has transferred the significant risks and rewards of ownership to the buyer;
∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
∙the amount of revenue can be measured reliably;
∙it is probable that the Company will receive the consideration due under the transaction; and
∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
∙the amount of revenue can be measured reliably;
∙it is probable that the Company will receive the consideration due under the contract;
∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and
∙the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
EARLY BREAST AWARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

2.Accounting policies (continued)


2.5
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
10%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 2).

Page 5

 
EARLY BREAST AWARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

4.


Tangible fixed assets


Plant and machinery

£



Cost or valuation


At 1 February 2025
11,707



At 31 January 2026

11,707



Depreciation


At 1 February 2025
2,134


Charge for the year on owned assets
1,171



At 31 January 2026

3,305



Net book value



At 31 January 2026
8,402



At 31 January 2025
9,573


5.


Debtors

As restated
2026
2025
£
£


Trade debtors
1,050
3,200

Other debtors
5,000
5,000

6,050
8,200



6.


Cash and cash equivalents

2026
2025
£
£

Cash at bank and in hand
29,814
24,136

29,814
24,136


Page 6

 
EARLY BREAST AWARE LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

7.


Creditors: Amounts falling due within one year

As restated
2026
2025
£
£

Trade creditors
1,872
1,036

Corporation tax
2,578
3,213

Other creditors
6,554
14,218

11,004
18,467



8.


Related party transactions

Dawn Chaplin and Andrew Chaplin are directors and shareholders of the company. 

During the year, the directors received loans of £7,664 from the company . As at the balance sheet date, the company owed the directors £6,554 (2025: £14,218) which is shown in Other Creditors due within one year.  

The above balance is payable on demand and therefore there are no significant differences between the value of the original loan amount and the initial carrying value of the loan as shown in the balance sheet.


Dawn Chaplin is also a director and shareholder of McDonald Mammography Consultancy Ltd.  

During the year, the company transacted with McDonald Mammography Consultancy Ltd for good and services for a net amount of £nil. As at the balance sheet date, the company was owed £5,000 (2025: £5,000) from McDonald Mammography Consultancy Ltd, which is shown in Other Debtors due within one year.

The above balance is payable on demand and therefore there are no significant differences between the value of the original loan amount and the initial carrying value of the loan as shown in the balance sheet.


9.


Controlling party

During the period the company was under the control of its directors.

 
Page 7